Orthox Announces MHRA Authorisation for Clinical Trial of Knee Cartilage Repair FibroFix™ Product Platform. Key Patent on Implantable Tissue Repair Devices Granted in Major Economies
Oxford, UK – 13 July 2022 – Orthox Limited, a clinical stage company developing medical implants to repair damaged knee articular cartilage and other orthopaedic injuries, anno
Orthox Closes $12.5m Series A Financing for Clinical Trials of Knee Cartilage Repair FibroFix™ Product Platform
Oxford, UK – 9th February 2022 – Orthox Limited, a clinical stage company developing medical implants to repair damaged knee articular cartilage and other orthopaedic injuries,
Orthox Secures Funds Approaching £3 million from Wellcome Trust and Technology Strategy Board to Support Clinical Development Programme
Oxford, UK – 29th October 2013 – Orthox Limited, the medical implant company developing strong, resilient, tissue regenerative silk implants, today announced awards worth £2.9
Orthox Secures Multiple Awards totalling £469k from Technology Strategy Board to fast track product pipeline
Oxford, UK – 29 July 2010 – Orthox Limited, the tissue repair company using silk technology, today announced two monetary awards worth £469k from the Technology Strategy Board
Orthox Secures Major Wellcome Trust Award
Kick starts development of innovative knee repair device based on silk technology Oxford, UK – 16 February 2009 – Orthox Limited, the tissue repair company using silk technolog